RBOT — Vicarious Surgical Income Statement
0.000.00%
Last trade - 00:00Annual income statement for Vicarious Surgical, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 38.2 | 80.1 | 80.7 | 66.6 | 50 |
| Operating Profit | -38.2 | -80.1 | -80.7 | -66.6 | -50 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -35.2 | 5.16 | -71.1 | -63.2 | -50.2 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -35.2 | 5.16 | -71.1 | -63.2 | -50.2 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -35.2 | 5.16 | -71.1 | -63.2 | -50.2 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -35.2 | 5.16 | -71.1 | -63.2 | -50.2 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -8.82 | 1.21 | -14.6 | -10.7 | -8.03 |